TVGN
Tevogen Bio Holdings Inc
NASDAQ: TVGN · HEALTHCARE · BIOTECHNOLOGY
$6.64
+3.43% today
Updated 2026-04-30
Market cap
$27.03M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.08
Dividend yield
—
52W range
$4 – $76
Volume
0.2M
Tevogen Bio Holdings Inc (TVGN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — |
| Cost of revenue | — | — | $378357.00 | $403581.00 |
| Gross profit | — | — | $-378357.00 | $-403581.00 |
| Gross margin | — | — | — | — |
| R&D | $2.96M | $5.77M | $4.40M | $31.03M |
| SG&A | $1.66M | $953083.00 | $2.27M | $22.53M |
| Operating income | $-4.62M | $-953083.00 | $-8.84M | $-53.56M |
| Operating margin | — | — | — | — |
| EBITDA | $-14.99M | $4.41M | $-58.89M | $-13.14M |
| EBITDA margin | — | — | — | — |
| EBIT | $-15.00M | $-1.18M | $-59.27M | $-13.54M |
| Interest expense | $598502.00 | $0.00 | $256031.00 | $184037.00 |
| Income tax | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-15.60M | $4.41M | $-60.48M | $-10.11M |
| Net income growth (YoY) | — | +128.3% | -1471.9% | +83.3% |
| Profit margin | — | — | — | — |